Septic encephalopathy. Etiology and management.

Area of Science:

• Biochemistry
• Neuroscience
• Critical Care Medicine

Background:

• Sepsis causes significant metabolic disturbances, affecting both liver and peripheral systems.
• Key changes include elevated aromatic and sulfur-containing amino acids, with normal or reduced branched-chain amino acids (BCAA).
• These metabolic shifts are linked to muscle protein breakdown and liver dysfunction.

Purpose of the Study:

• To investigate the role of altered amino acid profiles in sepsis-induced metabolic derangements.
• To explore the connection between metabolic changes and the pathophysiology of septic encephalopathy.
• To evaluate the potential therapeutic benefits of BCAA-enriched solutions in sepsis.

Main Methods:

• Analysis of plasma amino acid concentrations in septic patients.
• Assessment of brain amino acid and neurotransmitter levels.
• Evaluation of patient outcomes following administration of BCAA-enriched solutions (preliminary).

Main Results:

• Sepsis is associated with altered plasma amino acid levels, notably increased aromatic and sulfur-containing amino acids.
• Brain neurotransmitter levels are affected, with increased serotoninergic and decreased catecholaminergic activity observed.
• Preliminary findings suggest BCAA-enriched solutions may ameliorate metabolic derangements and septic encephalopathy.

Conclusions:

• Metabolic alterations, including changes in amino acids and neurotransmitters, are central to sepsis pathophysiology and septic encephalopathy.
• BCAA-enriched solutions show promise as a potential adjunctive therapy for metabolic derangements and neurological complications in sepsis.
• Further research is needed to confirm these preliminary findings and establish optimal treatment protocols.